![Vijay Tammara](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vijay Tammara
Corporate Officer/Principal chez
OCUGEN, INC.
Profil
Vijay Tammara is currently a Member at the American Association of Pharmaceutical Scientists, Vice President-Regulatory & Quality at Ocugen OpCo, Inc. since 2017, and Chief Development Officer at Ocugen, Inc. starting in 2025.
Former positions include Director-Regulatory Affairs at Merck & Co., Inc. from 2004 to 2010, Senior Associate Director at Wyeth Pharmaceuticals LLC from 2002 to 2004, Assistant Director at Sanofi-Synthelabo, Inc. in 2000, Team Leader-Clinical Pharmacology at the US Food & Drug Administration, and Vice President-Regulatory Affairs at Nuron Biotech, Inc. from 2010 to 2013.
Education includes a doctorate from the University of Louisiana at Monroe, a graduate degree from Nagpur University, and an undergraduate degree from Kakatiya University.
Postes actifs de Vijay Tammara
| Sociétés | Poste | Début |
|---|---|---|
| OCUGEN, INC. | Corporate Officer/Principal | 01/09/2019 |
American Association of Pharmaceutical Scientists
 American Association of Pharmaceutical Scientists BiotechnologyHealth Technology Engages in research and development of pharmaceutical products | Corporate Officer/Principal | - |
Ocugen OpCo, Inc. | Corporate Officer/Principal | 01/08/2017 |
Anciens postes connus de Vijay Tammara
| Sociétés | Poste | Fin |
|---|---|---|
Nuron Biotech, Inc.
 Nuron Biotech, Inc. BiotechnologyHealth Technology Markets and develops vaccines for the prevention and treatment of infectious diseases | Conseiller Juridique Général | 01/08/2013 |
| MERCK & CO., INC. | Conseiller Juridique Général | 01/09/2010 |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products | Corporate Officer/Principal | 01/03/2004 |
Sanofi-Synthelabo, Inc. | Corporate Officer/Principal | 01/09/2000 |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Corporate Officer/Principal | - |
Formation de Vijay Tammara
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
95
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products | Health Technology |
University of Louisiana at Monroe
 University of Louisiana at Monroe Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nagpur University
 Nagpur University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
Kakatiya University
 Kakatiya University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Association of Pharmaceutical Scientists
American Association of Pharmaceutical Scientists BiotechnologyHealth Technology Engages in research and development of pharmaceutical products | Health Technology |
Sanofi-Synthelabo, Inc. | Health Technology |
Nuron Biotech, Inc.
Nuron Biotech, Inc. BiotechnologyHealth Technology Markets and develops vaccines for the prevention and treatment of infectious diseases | Health Technology |
Ocugen, Inc.
 Ocugen, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes gene therapy products | Health Technology |
Ocugen OpCo, Inc. |
